Diretrizes de 2017 para manejo da hipertensão arterial em cuidados primários nos países de língua portuguesa

Abstract

The World Health Organization goal's to reduce mortality due to chronic non-communicable diseases by 2% per year demands a huge effort from member countries. This challenge for health professionals requires global political action on implementation of social measures, with cost-effective population interventions to reduce chronic non-communicable diseases and their risk factors. Systemic arterial hypertension is highly prevalent in Portuguese-speaking countries, and is a major risk factor for complications such as stroke, acute myocardial infarction and chronic kidney disease, rivaling dyslipidemia and obesity in importance for the development of atherosclerotic disease. Joint actions to implement primary prevention measures can reduce outcomes related to hypertensive disease, especially ischemic heart disease and stroke. It is essential to ensure the implementation of guidelines for the management of systemic hypertension via a continuous process involving educational actions, lifestyle changes and guaranteed access to pharmacological treatment.

Assistência do farmacêutico em pacientes com hipertensão

“…Nos hipertensos estágio 1 com risco cardiovascular moderado ou baixo, pode-se iniciar com MEV e aguardar 3 a 6 meses antes da decisão de começar a terapia medicamentosa. Nos demais estágios, recomenda-se iniciar a medicação hipertensiva tão logo tenha sido feito o diagnóstico (OLIVEIRA et al;2018, p.391).…”

Nível De Estresse E O Suporte Social De Idosos Praticantes E Não Praticantes De Exercício Físico

“…Dentre as doenças que acometem os idosos investigados neste estudo, destacam-se maior prevalência de hipertensão em ambos os grupos. Isto corrobora com as diretrizes, na qual a hipertensão é a doença mais comum em idosos (DE OLIVEIRA et al, 2017;WILLIAMS et al, 2018;FEITOSA-FILHO et al, 2019).…”

The Freedom of Clinicians and the Art of the Impossible

“…In addition, these Guidelines 10 published here have another very significant merit: they are the first scientific and pedagogical work by the FSCLP, which is something to be proud of. These Guidelines are aimed at meeting the goals of the FSCLP and at taking a big step towards the beginning of a "continuous process, involving mainly educational actions, lifestyle changes and guaranteed access to medicines" for hypertension, as stated in the document itself.…”